Please login to the form below

Not currently logged in
Email:
Password:

InnoPharma appoints Deborah DuFresne as VP

Will head strategic portfolio selection and management

Deborah DuFresne has joined InnoPharma as VP, strategic portfolio selection and management.

She joins the US-based company from Impax Laboratories where she was senior director, project management, product identification and development.

DuFresne has also held senior roles at Fera Pharmaceuticals, Sandoz and Apotex.

"Deborah's broad generic and specialty pharmaceutical experience and extensive product knowledge will be vital to InnoPharma as we seek to enhanc our portfolio in a strategic manner,” said InnoPharma's president and CEO Dr Navneet Puri.

“We look forward to working with Deborah as we continue to build our business and execute on our goals."

13th August 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics